Newton, MA, United States of America

Paula S Hochman

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 170(Granted Patents)


Location History:

  • Newtown, MA (US) (2007)
  • Brookline, MA (US) (1999 - 2012)
  • Newton, MA (US) (2002 - 2022)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Paula S. Hochman

Introduction

Paula S. Hochman, based in Newton, MA, is an accomplished inventor and scientist recognized for her significant contributions to the field of biotechnology and assay development. With a remarkable portfolio of 19 patents, she has made substantial advancements, particularly in the area of anti-integrin research.

Latest Patents

One of her notable inventions is related to anti-VLA-4 assays. This patent outlines Methods and apparatus for assaying the level of analytes in a sample associated with VLA-4. The described method includes steps such as contacting a biological sample with a detectable capture agent linked to a substrate that binds to an anti-integrin antibody found in the sample. Additionally, it details the process of detecting the binding of the capture agent with the anti-integrin antibody level and treating subjects with plasma exchange until the predetermined levels of the antibody are achieved.

Career Highlights

Throughout her career, Hochman has worked for prominent biotechnology companies, including Biogen Idec and Biogen, Incorporated. Her work has played an essential role in advancing therapeutic approaches and understanding diseases related to integrin pathways.

Collaborations

Paula Hochman has collaborated with several esteemed colleagues in her field, including Jeffrey L. Browning and Christopher D. Benjamin. These partnerships have not only fostered innovation but also enhanced the development of groundbreaking scientific methods and applications.

Conclusion

Paula S. Hochman's inventive spirit and dedication to research have established her as a key figure in biotechnology. Her patents reflect a commitment to innovation that can lead to impactful medical advancements, benefiting both clinical practices and patient outcomes. Her contributions not only underline her expertise but also encourage further exploration in the ever-evolving realm of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…